How does Wegovy work, explained simply

What this guide covers

Wegovy is semaglutide, a GLP-1 receptor agonist. It mimics a natural gut hormone to curb appetite, slow the stomach, and quiet food cravings. Here is what that means, step by step, and how the dose differs from Ozempic. This is patient education, not a substitute for the prescriber who knows your case. Generic names sit next to brand names throughout: semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound).

Key points

• The short answer. Wegovy is semaglutide (Ozempic, Wegovy), a once-weekly injection that works by mimicking a hormone your gut releases after meals, called GLP-1. It does three things at once: it reduces appetite by acting on the brain, it slows how fast your stomach empties so you feel full longer, and it supports steadier blood sugar. The mechanism is identical to Ozempic, because it is the same molecule; the difference is that Wegovy is dosed higher and approved for weight management, which is why the appetite effect is the headline. It is not a stimulant, a fat-burner, or a metabolism booster. It is a long-acting copy of a satiety hormone you already make.
• The GLP-1 hormone it copies. GLP-1, glucagon-like peptide-1, is released by your intestines when food arrives, and its natural job is to manage the after-meal response: signal fullness, prompt insulin, and slow digestion. Your own GLP-1 lasts only a few minutes before it breaks down. Semaglutide is engineered to resist that breakdown, so a single injection delivers a steady GLP-1 signal for about a week. Because it activates the same receptors your body uses, the appetite changes feel less like fighting hunger and more like the hunger volume being turned down. This is the foundation of everything Wegovy does, and it is the same foundation as Ozempic and Rybelsus.
• Effect one: appetite and 'food noise'. GLP-1 receptors sit in the appetite centers of the brain, and when Wegovy activates them at its higher dose, most people feel satisfied with noticeably less food and notice the constant background pull toward the next snack quieting down. Many describe it as 'food noise' fading. This is the core of how Wegovy supports weight management: not by forcing willpower, but by changing the appetite signal itself. It can feel like a relief and can also take some adjusting to, since eating becomes less automatic. The STEP trials attribute the weight outcomes primarily to this appetite mechanism.
• Effect two: the stomach empties more slowly. Wegovy slows gastric emptying, the rate at which your stomach passes food into the intestine, which keeps you full longer after meals. This helps appetite, and it is also the direct source of most side effects: when the stomach empties slowly, food sits and ferments (nausea, sulfur burps, reflux) and transit downstream slows (constipation). At Wegovy's higher dose these can be a bit more noticeable during escalation. None of it means the drug is failing; it is the mechanism working. Our nausea and constipation guides cover what genuinely helps, and they apply equally to Wegovy and Ozempic.
• Effect three: blood sugar, even though it is a weight drug. Even though Wegovy is approved for weight management rather than diabetes, the glucose mechanism is still there because it is semaglutide. It supports glucose-dependent insulin release, meaning the pancreas releases insulin mainly when blood sugar is high, and it suppresses glucagon, which otherwise tells the liver to release more sugar. The result is steadier blood sugar as a built-in effect. Because the insulin action is glucose-dependent, semaglutide alone carries a low risk of hypoglycemia; that risk rises mainly if it is combined with insulin or a sulfonylurea, which is a prescriber's dosing decision.

Frequently asked questions